Indeed, mice expressing high systemic levels of FGF-23 (R176Q) exhibit hypocalcemia and subsequent development of secondary HPT, even though their elevated PTH levels are likely to aggravate the prevailing hypophosphatemia [33]. The gene discussed is FGF23; the disease is hypophosphatemia.